|
|
|
|
|
|
|
May 23, 2012 |
|
Proteogenix is a corporation based in Portland, Oregon that develops and markets biomarker diagnostic tests for the detection of life-threatening pregnancy-related conditions. Proteogenix is currently developing non-invasive protein biomarker screening tests for intra-amniotic infection, premature birth, and Down syndrome. The development of these tests could lead to the prevention of 175,000 premature births each year in the United States alone.<ref name="alone"> cite news |url=http://biospace.com/news_company.aspx?CompanyID=2045 |publisher=Biospace.com |title=ProteoGenix News from The BioSpace Beat |date=September 29, 2004 </ref> <references/>
Category:Companies based in Oregon Category:Obstetrics Category:Pregnancy This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Proteogenix".
|
||||||||||||||||||||||||
|
|
|
||
|
All informatin on the site is © www.woman-health.org 2002-2011. Last revised: January 2, 2011 Are you interested in our site or/and want to use our information? please read how to contact us and our copyrights. To let us provide you with high quality information, you can help us by making a more or less donation: |